Impact of aging on cancer immunity and immunotherapy Graham PawelecJoseph LustgartenClaudia Gravekamp Editorial 29 July 2009 Pages: 1907 - 1908
Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53 Stefano SalvioliMiriam CapriClaudio Franceschi Symposium in Writing 13 January 2009 Pages: 1909 - 1917
Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach Calogero CarusoCarmela Rita BalistreriSonya Vasto Symposium in Writing 17 February 2009 Pages: 1919 - 1933
Mechanisms of murine dendritic cell antitumor dysfunction in aging Annabelle Grolleau-JuliusLisa AbernathyRaymond L. Yung Symposium in Writing 13 December 2008 Pages: 1935 - 1939
The effect of aging on OX40 agonist-mediated cancer immunotherapy Carl E. RubyAndrew D. Weinberg Symposium in Writing 14 March 2009 Pages: 1941 - 1947
Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged Yu Cheng TangMarilyn ThomanAlbert Deisseroth Symposium in Writing 15 May 2009 Pages: 1949 - 1957
Immunosenescence and cancer vaccines Mauro Provinciali Symposium in Writing 06 February 2009 Pages: 1959 - 1967
The importance of the age factor in cancer vaccination at older age Claudia Gravekamp Symposium in Writing 04 March 2009 Pages: 1969 - 1977
Cancer, aging and immunotherapy: lessons learned from animal models Joseph Lustgarten Symposium in Writing 24 February 2009 Pages: 1979 - 1989
2B4 (CD244) signaling via chimeric receptors costimulates tumor-antigen specific proliferation and in vitro expansion of human T cells Bianca AltvaterSilke LandmeierClaudia Rossig Original article 10 April 2009 Pages: 1991 - 2001
Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia Nelson R. TironeBethanea C. PeghiniMarcia A. Michelin Original Article 18 April 2009 Pages: 2003 - 2010
Rejection of intradermally injected syngeneic tumor cells from mice by specific elimination of tumor-associated macrophages with liposome-encapsulated dichloromethylene diphosphonate, followed by induction of CD11b+/CCR3−/Gr-1− cells cytotoxic against the tumor cells Takeshi TakahashiMinenori IbataRyotaro Yoshida Original Article 14 April 2009 Pages: 2011 - 2023
A genetic variant of immunoglobulin γ2 is strongly associated with immunity to mucin 1 in patients with breast cancer Janardan P. PandeyPaul J. NietertOleg Kurtenkov Original Article 14 April 2009 Pages: 2025 - 2029
Bortezomib pre-treatment prolongs interferon-alpha-induced STAT1 phosphorylation in melanoma cells Gregory B. LesinskiKristen BenningerWilliam E. Carson III Original Article 26 April 2009 Pages: 2031 - 2037
Identification and modification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from Ran antigen Fan LiDi YangYuzhang Wu Original Article 09 May 2009 Pages: 2039 - 2049
Dose, timing, schedule, and the choice of targeted epitope alter the efficacy of anti-CD22 immunotherapy in mice bearing human lymphoma xenografts Robert T. O’DonnellYunpeng MaJoseph M. Tuscano Original Article Open access 13 May 2009 Pages: 2051 - 2058
Downregulation of interleukin-7 and hepatocyte growth factor in the thymic microenvironment is associated with thymus involution in tumor-bearing mice Roberto CarrioNorman H. AltmanDiana M. Lopez Original Article 07 May 2009 Pages: 2059 - 2072
Graft versus neuroblastoma reaction is efficiently elicited by allogeneic bone marrow transplantation through cytolytic activity in the absence of GVHD Shifra AshVered GigiIsaac Yaniv Original Article 13 May 2009 Pages: 2073 - 2084
